Skip to main content
Equibles

BARCLAYS PLC

Position in NUVB — Nuvation Bio Inc.

CIK 312069 LONDON, X0
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,316,589
+$825,424 QoQ
Shares Held
231,794
+102.5% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 242 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. NUVB ranks #102 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
 1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in NUVB

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,316,589 231,794
2026-03-31 $491,165 114,491
2025-12-31 $3,935,876 439,272
2025-09-30 $1,834,954 495,934
2025-06-30 $1,988,149 1,019,565
2025-03-31 $2,375,582 1,349,763
2024-12-31 $3,404,033 1,279,712
2024-09-30 $2,789,955 1,218,321
2024-06-30 $4,532,242 1,552,138
2024-03-31 $5,844,769 1,605,706
2023-12-31 $734,995 486,752
2023-09-30 $137,094 102,309
2023-06-30 $189,277 105,154
2023-03-31 $372,633 224,478
2022-12-31 $131,447 68,462
2022-09-30 $126,678 56,553
2022-06-30 $172,290 53,176
2022-03-31 $320,449 60,922